Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Fermented foods such as yoghurt and cheese could be a source of health-promoting bacteria, according to a new study.
Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.
Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.
A. Macpherson et al. reviewed studies that looked at the interaction between the gut microbiota and their mammalian hosts, from fetal development to the early postnatal period.
Obese people have a gut microbiota that is associated with inflammation. But those who take statins have a healthier gut microbiota, a new study (Nature) found.
The American Gastroenterological Association (AGA) evaluated available evidence on clinical efficacy of probiotics for most digestive conditions.
Ebselen may protect from C. difficile-associated tissue damage and bolster recovery of the microbiota after antibiotic treatment.
A new study shows that interactions with the resident gut microbiota could suppress the proliferation and antibiotic-resistance evolution of superbugs.
A new study supports the idea that the gut microbiota composition can vary in abundance and function during the development of colorectal cancer.
In a commentary published in Cell, five experts discuss the challenges and opportunities of microbiota-based therapies.
